Center-Authored Papers

Filters: Author is Dubois, Robert W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Dubois RW, Pinto LA, Bernal M, Badamgarav E, Lyman GH.  2004.  Benefits of GM-CSF Versus Placebo or G-CSF in Reducing Chemotherapy-Induced Complications: A Systematic Review of the Literature.. Supportive cancer therapy. 2(1):34-41. Abstract
C
Lyman G, Lalla A, Barron R, Dubois RW.  2009.  Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States.. Current medical research and opinion. 25(2):401-11. Abstract
Lyman GH, Lalla A, Barron RL, Dubois RW.  2009.  Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States.. Clinical therapeutics. 31(5):1092-104. Abstract
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH.  2009.  Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2):217-25. Abstract